Indivior (INDV) insider buying

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $4.1B

7 open-market purchases of INDV by Indivior's executives and directors since January 2026, worth $203,342 in total, from SEC Form 4 filings.

The most recent: Barbara Ryan bought $1,009 on March 9, 2026.

The biggest buyer over the period is David E Wheadon: 1 purchase, $62,676.

By year

YearPurchasesValue
20267$203,342

Biggest buyers

InsiderBuysValue
David E Wheadon
1$62,676
Stuart A Kingsley
1$29,948
Barbara Ryan
2$28,437
Daniel A Ninivaggi
1$27,427
Keith Humphreys
1$27,427
Mark Stejbach
1$27,427

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 9, 2026 Barbara Ryan
31$32.56$1,009 Form 4
Mar 6, 2026 Stuart A Kingsley
940$31.86$29,948 Form 4
Jan 5, 2026 Daniel A Ninivaggi
775$35.39$27,427 Form 4
Jan 5, 2026 Keith Humphreys
775$35.39$27,427 Form 4
Jan 5, 2026 Mark Stejbach
775$35.39$27,427 Form 4
Jan 5, 2026 David E Wheadon
1,771$35.39$62,676 Form 4
Jan 5, 2026 Barbara Ryan
775$35.39$27,427 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INDV.
Open INDV in Investingly

Questions

Are Indivior insiders buying the stock?

7 open-market purchases of INDV by Indivior's executives and directors since January 2026, worth $203,342 in total, from SEC Form 4 filings. The most recent: Barbara Ryan bought $1,009 on March 9, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Indivior's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.